BR112023017222A2 - Composto que é um triazol de 2-oxo-1-pirrolidinila substituído de fórmula (i), e, composição farmacêutica compreendendo um composto que é um triazol de 2-oxo-1-pirrolidinila substituído de fórmula (i) - Google Patents
Composto que é um triazol de 2-oxo-1-pirrolidinila substituído de fórmula (i), e, composição farmacêutica compreendendo um composto que é um triazol de 2-oxo-1-pirrolidinila substituído de fórmula (i)Info
- Publication number
- BR112023017222A2 BR112023017222A2 BR112023017222A BR112023017222A BR112023017222A2 BR 112023017222 A2 BR112023017222 A2 BR 112023017222A2 BR 112023017222 A BR112023017222 A BR 112023017222A BR 112023017222 A BR112023017222 A BR 112023017222A BR 112023017222 A2 BR112023017222 A2 BR 112023017222A2
- Authority
- BR
- Brazil
- Prior art keywords
- pyrrolidinyl
- triazole
- oxo
- substituted
- compound
- Prior art date
Links
- -1 2-OXO-1-PYRROLIDINYL TRIAZOLE Chemical class 0.000 title abstract 5
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
composto que é um triazol de 2-oxo-1-pirrolidinila substituído de fórmula (i), e, composição farmacêutica compreendendo um composto que é um triazol de 2-oxo1-pirrolidinila substituído de fórmula (i). a invenção refere-se à administração em dosagens específicas de um composto que é um triazol de 2-oxo-1-pirrolidinila substituído de fórmula (i) ou um isômero ou um sal farmaceuticamente aceitável do mesmo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21159595 | 2021-02-26 | ||
| PCT/EP2022/053498 WO2022179873A1 (en) | 2021-02-26 | 2022-02-14 | Compound for treatment of cognitive disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023017222A2 true BR112023017222A2 (pt) | 2023-11-21 |
Family
ID=74797814
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023017222A BR112023017222A2 (pt) | 2021-02-26 | 2022-02-14 | Composto que é um triazol de 2-oxo-1-pirrolidinila substituído de fórmula (i), e, composição farmacêutica compreendendo um composto que é um triazol de 2-oxo-1-pirrolidinila substituído de fórmula (i) |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP4297749A1 (pt) |
| JP (1) | JP2024508052A (pt) |
| KR (1) | KR20230167032A (pt) |
| CN (1) | CN117177746A (pt) |
| AR (1) | AR124967A1 (pt) |
| AU (1) | AU2022226335A1 (pt) |
| BR (1) | BR112023017222A2 (pt) |
| CA (1) | CA3209858A1 (pt) |
| IL (1) | IL305471A (pt) |
| MX (1) | MX2023010044A (pt) |
| TW (1) | TW202245754A (pt) |
| UY (1) | UY39649A (pt) |
| WO (1) | WO2022179873A1 (pt) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8412357D0 (en) | 1984-05-15 | 1984-06-20 | Ucb Sa | Pharmaceutical composition |
| US20120171125A1 (en) * | 2009-08-07 | 2012-07-05 | Ucb Pharma, S.A. | Methods for Enhancing the Cognitive Function |
| WO2014012563A1 (en) * | 2012-07-20 | 2014-01-23 | Ucb Pharma, S.A. | Compounds for enhancing the cognitive function |
| HUE037644T2 (hu) | 2013-08-02 | 2018-09-28 | Ucb Biopharma Sprl | Vegyületek a kognitív funkció növelésére |
-
2022
- 2022-02-14 IL IL305471A patent/IL305471A/en unknown
- 2022-02-14 WO PCT/EP2022/053498 patent/WO2022179873A1/en active Application Filing
- 2022-02-14 JP JP2023576246A patent/JP2024508052A/ja active Pending
- 2022-02-14 AU AU2022226335A patent/AU2022226335A1/en active Pending
- 2022-02-14 CA CA3209858A patent/CA3209858A1/en active Pending
- 2022-02-14 BR BR112023017222A patent/BR112023017222A2/pt unknown
- 2022-02-14 EP EP22705540.7A patent/EP4297749A1/en active Pending
- 2022-02-14 MX MX2023010044A patent/MX2023010044A/es unknown
- 2022-02-14 KR KR1020237032797A patent/KR20230167032A/ko unknown
- 2022-02-14 CN CN202280029058.1A patent/CN117177746A/zh active Pending
- 2022-02-24 AR ARP220100405A patent/AR124967A1/es unknown
- 2022-02-25 UY UY0001039649A patent/UY39649A/es unknown
- 2022-02-25 TW TW111107164A patent/TW202245754A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022179873A1 (en) | 2022-09-01 |
| CN117177746A (zh) | 2023-12-05 |
| UY39649A (es) | 2022-09-30 |
| JP2024508052A (ja) | 2024-02-21 |
| AU2022226335A1 (en) | 2023-09-21 |
| MX2023010044A (es) | 2023-11-09 |
| TW202245754A (zh) | 2022-12-01 |
| KR20230167032A (ko) | 2023-12-07 |
| CA3209858A1 (en) | 2022-09-01 |
| EP4297749A1 (en) | 2024-01-03 |
| AR124967A1 (es) | 2023-05-24 |
| IL305471A (en) | 2023-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112021009595A2 (pt) | Terapia de combinação incluindo um inibidor de krasg12c e um ou mais agentes farmaceuticamente ativos adicionais para o tratamento de cânceres | |
| BR112022019557A2 (pt) | Inibidores de replicação de norovírus e coronavírus | |
| MA40814A1 (fr) | Compositions pharmaceutiques pour thérapie combinée | |
| CO2023008018A2 (es) | Nuevos agentes antivirales derivados de la espiropirrolidina | |
| MA46101A (fr) | Modulateurs allostériques positifs du récepteur muscarinique m1 | |
| UY37133A (es) | Derivados de pirazolo[1,5-a]pirazin-4-ilo | |
| ES2194195T3 (es) | N-((4-(5-metil-3-fenililxazol-4-il)fenil)sulfonilpropanamida y su sal sodica como profarmacos de inhibnidores de cox-2. | |
| BRPI0714055B8 (pt) | compostos moduladores de propriedades farmacocinéticas de terapêuticos, composições farmacêuticas que compreendem os referidos compostos e usos dos mesmo | |
| BRPI0407618A (pt) | derivados de tiazole amino substituidos com cicloalquilo contendo n e composições farmacêuticas para inibição da proliferação celular e métodos para a sua utilização | |
| BR112013017302A2 (pt) | formulações de imunossupressor | |
| BR112015022092A8 (pt) | derivado de di-hidropiridazina-3,5-diona, seu uso e agente preventivo e/ou terapêutico comprendendo o mesmo | |
| BR112023022484A2 (pt) | Composto na fórmula geral (i) ou um sal farmaceuticamente aceitável deste, composição farmacêutica e uso do composto ou sais farmaceuticamente aceitáveis deste | |
| MA43913A (fr) | Modulateurs allostériques positifs du récepteur m1 muscarinique | |
| BR112023022050A2 (pt) | Agonistas do receptor de orexina e usos destes | |
| MA50069B1 (fr) | Dérivés 1-(4-(isoxazol-5-yl)-1h-pyrazol-1-yl)-2-méthylpropan-2-ol et composés similaires en tant qu'inhibiterus il-7 et ifn-gamma pour le traitement de maladies autoimmune et inflammation chronique | |
| PH12020551772A1 (en) | Oxo-substituted compound | |
| PH12020551341A1 (en) | 4-methyldihydropyrimidinone compounds and pharmaceutical use thereof | |
| CL2022002641A1 (es) | Agente para el tratamiento de lesión renal aguda inducida por medio de contraste | |
| MX2021003508A (es) | Derivados de 5-azaindazol como antagonistas del receptor de adenosina. | |
| MX2023001823A (es) | Terapia de combinacion. | |
| BR112023017222A2 (pt) | Composto que é um triazol de 2-oxo-1-pirrolidinila substituído de fórmula (i), e, composição farmacêutica compreendendo um composto que é um triazol de 2-oxo-1-pirrolidinila substituído de fórmula (i) | |
| MX2022008487A (es) | Degradadores de smarca2-vhl. | |
| BR112021006424A2 (pt) | inibidores de quinase tyk2 | |
| MA52375B2 (fr) | Inhibiteurs de cdk8/19 | |
| MA32128B1 (fr) | Association entre un sel de bis-thiazolium ou l'un de ses precurseurs et l'artémisinine ou l'un de ses derives pour le traitement du paludisme severe |